Japan Food Allergy Treatment Market Size, Share, and COVID-19 Impact Analysis, By Allergen Type (Dairy Products, Peanuts, and Poultry Products), By Drug Type (Antihistamines, Epinephrine, and Immunotherapy), and Japan Food Allergy Treatment Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareJapan Food Allergy Treatment Market Insights Forecasts to 2035
- The Japan Food Allergy Treatment Market Size Was Estimated at USD 221.8 Million in 2024
- The Market Size is Expected to Grow at a CAGR of Around 8.08% from 2025 to 2035
- The Japan Food Allergy Treatment Market Size is Expected to Reach USD 521.5 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights & Consulting, The Japan Food Allergy Treatment Market Size is anticipated to grow from USD 221.8 Million in 2024 to USD 521.5 Million by 2035, growing at a CAGR of 8.08% from 2025 to 2035. The Japan food allergy treatment market is rising rapidly due to various factors, including the rising prevalence of food allergies, the adoption of biological agents to treat food allergies, increased awareness, rising demand for personalized medicines and advancements in immunotherapy.
Report Coverage
This research report categorizes the market for the Japan food allergy treatment market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan food allergy treatment market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan food allergy treatment market.
Japan Food Allergy Treatment Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 221.8 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 8.08% |
2035 Value Projection: | USD 521.5 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 257 |
Tables, Charts & Figures: | 108 |
Segments covered: | By allergy type and By Drug Type |
Companies covered:: | Sanofi, Teva Pharmaceutical Industries Ltd., Novartis AG, F. Hoffmann-La Roche Ltd., Toray Industries, Torii Pharmaceutical Co.,Ltd., and Other |
Pitfalls & Challenges: | COVID-19 has the potential to impact the global market |
Get more details on this report -
Driving Factors
One of the notable driving factors is that people are becoming aware of food allergies and their treatments. The change in lifestyle and consumption of unhealthy diets leads to various allergic reactions, including food allergies. The advancements in diagnostic technologies and accessibility of innovative therapies drive the demand for more effective treatments and management strategies. Additionally, the government is taking initiatives by strict regulations on food labelling and funding for allergy research, which supports the market growth.
Restraining Factors
The Japan food allergy treatment market has several obstacles. The advanced food allergy treatments, like biologics and oral immunotherapy, are expensive, which limits accessibility for many patients. Additionally, the immunotherapy has several allergic reactions that have led to hesitation among people and physicians.
Market Segmentation
The Japan food allergy treatment market share is classified into allergen type and drug type.
- The peanuts segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Japan food allergy treatment market is segmented by allergen type into dairy products, peanuts, and poultry products. Among these, the peanuts segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the rising prevalence of peanut allergies. Additionally, the increased application of novel biologic agents to treat the allergy.
- The epinephrine segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Japan food allergy treatment market is segmented by drug type into antihistamines, epinephrine, and immunotherapy. Among these, the epinephrine segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to a rise in cases of food allergies. Additionally, the rising awareness of anaphylaxis among patients led to greater adoption of autoinjectors.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan food allergy treatment market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of key Companies
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- F. Hoffmann-La Roche Ltd.
- Toray Industries
- Torii Pharmaceutical Co.,Ltd.
- Other
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan food allergy treatment market based on the below-mentioned segments:
Japan Food Allergy Treatment Market, By Allergen Type
- Dairy Products
- Peanuts
- Poultry Products
Japan Food Allergy Treatment Market, By Drug Type
- Antihistamines
- Epinephrine
- Immunotherapy
Need help to buy this report?